|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/10/13 Opko Health, Inc. 10-Q 3/31/13 76:9.1M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 632K
2: EX-2.10 Plan of Acquisition, Reorganization, Arrangement, HTML 369K
Liquidation or Succession
3: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 21K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
52: R1 Document and Entity Information HTML 41K
40: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 147K
50: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 73K
(Parenthetical)
54: R4 Condensed Consolidated Statements of Operations HTML 116K
(Unaudited)
70: R5 Condensed Consolidated Statements of Comprehensive HTML 42K
Loss (Unaudited)
42: R6 Condensed Consolidated Statement of Shareholders' HTML 95K
Equity (Unaudited)
49: R7 Condensed Consolidated Statement of Shareholders' HTML 25K
Equity (Unaudited) (Parenthetical)
36: R8 Condensed Consolidated Statements of Cash Flows HTML 185K
(Unaudited)
27: R9 Business and Organization HTML 34K
71: R10 Summary of Significant Accounting Policies HTML 48K
56: R11 Loss Per Share HTML 28K
55: R12 Composition of Certain Financial Statement HTML 60K
Captions
61: R13 Acquisitions, Investments, and Licenses HTML 107K
62: R14 Debt HTML 87K
59: R15 Accumulated Other Comprehensive Income HTML 37K
63: R16 Fair Value Measurements HTML 158K
51: R17 Derivative Contracts HTML 71K
53: R18 Related Party Transactions HTML 40K
58: R19 Commitments and Contingencies HTML 33K
76: R20 Segments HTML 68K
66: R21 Series D Preferred Stock Redemption HTML 35K
45: R22 Subsequent Events HTML 25K
57: R23 Summary of Significant Accounting Policies HTML 119K
(Policies)
47: R24 Composition of Certain Financial Statement HTML 59K
Captions (Tables)
20: R25 Acquisitions, Investments, and Licenses (Tables) HTML 95K
67: R26 Debt (Tables) HTML 86K
73: R27 Accumulated Other Comprehensive Income (Tables) HTML 32K
31: R28 Fair Value Measurements (Tables) HTML 158K
30: R29 Derivative Contracts (Tables) HTML 65K
34: R30 Segments (Tables) HTML 59K
35: R31 Summary of Significant Accounting Policies HTML 60K
(Details)
37: R32 Loss Per Share (Details) HTML 33K
18: R33 Composition of Certain Financial Statement HTML 124K
Captions (Details)
64: R34 Acquisitions, Investments, and Licenses (Details) HTML 43K
44: R35 Acquisitions, Investments, and Licenses (Details HTML 31K
1)
46: R36 Acquisitions, Investments, and Licenses (Details HTML 67K
2)
23: R37 Acquisitions, Investments, and Licenses (Details HTML 90K
3)
75: R38 Acquisitions, Investments, and Licenses (Details HTML 193K
Textual)
13: R39 Debt (Details) HTML 38K
38: R40 Debt (Details 1) HTML 27K
69: R41 Debt (Details 2) HTML 33K
22: R42 Debt (Details 3) HTML 53K
29: R43 Debt (Details 4) HTML 33K
33: R44 Debt (Details Textual) HTML 86K
41: R45 Accumulated Other Comprehensive Income (Details) HTML 49K
17: R46 Accumulated Other Comprehensive Income (Details HTML 34K
Textual)
26: R47 Fair Value Measurements (Details) HTML 47K
15: R48 Fair Value Measurements (Details 1) HTML 57K
68: R49 Fair Value Measurements (Details 2) HTML 31K
21: R50 Fair Value Measurements (Details 3) HTML 45K
65: R51 Fair Value Measurements (Details Textual) HTML 51K
24: R52 Derivative Contracts (Details) HTML 30K
39: R53 Derivative Contracts (Details 1) HTML 27K
14: R54 Derivative Contracts (Details 2) HTML 38K
16: R55 Derivative Contracts (Details Textual) HTML 27K
32: R56 Related Party Transactions (Details) HTML 172K
19: R57 Commitments and Contingencies (Details) HTML 41K
72: R58 Segments (Details) HTML 67K
43: R59 Segments (Details Textual) HTML 45K
60: R60 Series D Preferred Stock Redemption (Details) HTML 36K
25: R61 Subsequent Events (Details) HTML 33K
74: XML IDEA XML File -- Filing Summary XML 113K
28: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.36M
7: EX-101.INS XBRL Instance -- opk-20130331 XML 1.97M
9: EX-101.CAL XBRL Calculations -- opk-20130331_cal XML 231K
10: EX-101.DEF XBRL Definitions -- opk-20130331_def XML 978K
11: EX-101.LAB XBRL Labels -- opk-20130331_lab XML 1.51M
12: EX-101.PRE XBRL Presentations -- opk-20130331_pre XML 1.14M
8: EX-101.SCH XBRL Schema -- opk-20130331 XSD 232K
48: ZIP XBRL Zipped Folder -- 0001193125-13-212997-xbrl Zip 193K
| EX-32.2 |
Exhibit 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 73 of Title 18, United States Code)
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant section 906 of the Sarbanes-Oxley Act of 2002, I, Juan F. Rodriguez, Chief Financial Officer of OPKO Health, Inc. (the “Company”), hereby certify that:
The Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2013 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 10, 2013
| Juan F. Rodriguez |
| Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/10/13 | 4, 8-K | ||
| For Period end: | 3/31/13 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/18/21 Opko Health, Inc. 10-K 12/31/20 111:16M |